Recombinant SUMO Conjugating Enzyme UBC9 Monoclonal Antibody
Sizes: 50μL, 100μL
Catalogue Numbers: E-AB-81514-50, E-AB-81514-100
Citations, Manuals and MSDS Available upon request.
Abbreviation: SUMO Conjugating Enzyme UBC9
Target Synonym: Ubiquitin Conjugating Enzyme E2 I; RING-Type E3 SUMO Transferase UBC9; SUMO-Conjugating Enzyme UBC9; Ubiquitin Carrier Protein 9; Ubiquitin Carrier Protein I; Ubiquitin-Protein Ligase I; SUMO-Protein Ligase; UBC9; P18; Ubiquitin-Like Protein SUMO-1 Conjugating Enzyme; Ubiquitin-Conjugating Enzyme UbcE2A; Ubiquitin Conjugating Enzyme E2; Ubiquitin Conjugating Enzyme 9; C358B7.1; EC 6.3.2; UBCE9
Research Areas: Cancer, Cell Biology, Epigenetics and Nuclear Signaling, Metabolism
Conjugation: Unconjugated
Host: Rabbit
Species Reactivity: Human, Mouse, Rat
Application: WB, IHC-P
Isotype: IgG
Clonality: Rabbit Monoclonal
Clone No.: R01-6I6
UNIProt ID: P63279
Background: UBE2I is also named as UBC9, UBCE9 and belongs to the ubiquitin-conjugating enzyme family. It is a homologue of the E2 ubiquitin conjugating enzyme and participates in thecovalent linking of SUMO-1 molecule to the target protein. This protein is present at a high level in spleen and lung. Moderate level of UBE2I is detected in kidney and liver. Low amount of UBE2I is observed in brain, whereas the 18 kDa band of UBE2I is barely visible or absent in heart and skeletal muscle. In heart and muscle extracts the UBE2I antibodies recognizes a 38 kDa protein band, but this band is not visible in extracts of other rat tissues.
Concentration: 300 μg/mL
Immunogen: A synthetic peptide of human UBE2I/UBC9
Buffer: 50mM Tris-Glycine(pH 7.4), 0.15M NaCl, 40% Glycerol, 0.01% Sodium azide and 0.05% protective protein
Purification Method: Affinity Purified
Dilution: WB 1:500-1:1000 IHC 1:50-1:100
Calculated MW: 18kDa
Observed MW: 18kDa
Storage: -20°C/One year. Avoid freeze / thaw cycles.
Shipping: Ice bag
Research Use Only